Jefferies Group ARKG Holdings History

Number of Shares
1.30 Mil
Current Holdings Value*
$54.68 Mil
% of Portfolio
0.37%
Total Estimate Gain
$27.66 Mil
% of Total Estimate Gain
47.59%

Jefferies Group's ARK Genomic Revolution ETF Holding Summary

As of 2026-06-30, Leucadia National held 1.30 Mil shares of ARK Genomic Revolution ETF(ARKG), totaling $54.68 Mil. This investment constitutes 0.37% of their stock portfolio, and Leucadia National now holds 3.24% of the outstanding ARK Genomic Revolution ETF(ARKG) stock.

The initial trade took place in 2022Q4. And since then Jefferies Group has made 5 purchases of ARKG, at an average price of $30.78, for a total of 1.89 Mil shares. In addition, there have been 4 sales at an average price of $27.38 for 88,005.00 shares. Based on historical transaction data and ARKG's current price of $46.31, Jefferies Group's estimated gain on his ARKG holdings is $27.66 Mil, reflecting a 47.59% gain to date.

Jefferies Group ARKG ($46.31) Holding Chart

Jefferies Group ARKG ($46.31) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Articles on ARK Genomic Revolution ETF

No articles.

Top Ranked Articles

  • 1